Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Beck

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Research Communications|July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC ModelsBenjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Cancer Research Communications|March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine XenograftsYasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Cancers|August 26, 2023
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric RhabdomyosarcomaJerry T Wu, Adam Cheuk, Kristine Isanogle, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Nucleic Acids Research|October 22, 2009
Pathema: a clade-specific bioinformatics resource center for pathogen researchLauren M Brinkac, Tanja Davidsen, Erin Beck, et al.
Nature Communications|October 3, 2022
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Nature Communications|September 17, 2022
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Nature Communications|June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancerNishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Cancer Cell|April 13, 2021
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressAnish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research Communications|July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC ModelsBenjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Cancer Research Communications|March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine XenograftsYasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Cancers|August 26, 2023
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric RhabdomyosarcomaJerry T Wu, Adam Cheuk, Kristine Isanogle, et al.
Nature Communications|June 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complexYilun Sun, Simone A Baechler, Xiaohu Zhang, et al.
Nucleic Acids Research|October 22, 2009
Pathema: a clade-specific bioinformatics resource center for pathogen researchLauren M Brinkac, Tanja Davidsen, Erin Beck, et al.
Nature Communications|October 3, 2022
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Nature Communications|September 17, 2022
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.
Nature Communications|June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancerNishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Cancer Cell|April 13, 2021
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stressAnish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, et al.
Pageof 3